CBAT
CBAK Energy Technology, Inc.
There isn't enough reported data to score CBAT yet.
RKLB
Rocket Lab USA, Inc.
RKLB lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
CBAT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Strong | |
| Weak |
CBAT's revenue and cash flow are currently strong, but its profitability and balance sheet are weak.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
CBAT PE Valuation
CBAT has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 4.8x next year's earnings.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
CBAT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect CBAT to return to profit, with revenue growing.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
CBAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.20 | — |
| Q1 2026 | -$0.18 | -$0.18 |
| Q4 2025 | -$0.10 | -177% |
| Q3 2025 | -$0.07 | -154% |
| Q2 2025 | -$0.10 | -150% |
| Q1 2025 | $0.00 | -100% |
| Q4 2024 | $0.13 | +$0.16 |
| Q3 2024 | $0.13 | +$0.23 |
| Q2 2024 | $0.20 | +$0.37 |
CBAT is still losing money, but less than at its worst: $0.18 per share over the past year, against $0.35 at its worst in late 2019.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
CBAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $69.6M | +99% |
| Q4 2025 | $58.8M | +132% |
| Q3 2025 | $60.9M | +37% |
| Q2 2025 | $40.5M | -15% |
| Q1 2025 | $34.9M | -41% |
| Q4 2024 | $25.4M | -55% |
| Q3 2024 | $44.6M | -30% |
| Q2 2024 | $47.8M | +13% |
CBAT has the stronger quarterly revenue trend. Revenue is up 99% for CBAT versus up 73% for RKLB.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2026 | -14% | -5.7 points |
| Q4 2025 | -14% | +12 points |
| Q3 2025 | -6.6% | -4.8 points |
| Q2 2025 | -8.7% | -21 points |
| Q1 2025 | -8.2% | -26 points |
| Q4 2024 | -26% | -16 points |
| Q3 2024 | -1.9% | -10 points |
| Q2 2024 | 12% | +21 points |
CBAT's operating margin was −14% last quarter, down 5.7 points from the same quarter a year ago.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB's revenue has grown year over year every quarter since late 2021: $268M last quarter, up 73% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
CBAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | $10.5M | +$32.8M |
| Q4 2025 | $16.1M | +310% |
| Q3 2025 | $6M | -64% |
| Q2 2025 | $4.1M | +65% |
| Q1 2025 | -$22.3M | -$21.9M |
| Q4 2024 | $3.9M | -80% |
| Q3 2024 | $16.5M | +$17M |
| Q1 2024 | -$454K | -105% |
CBAT has the stronger cash trend. Its trailing FCF is up 6,165% versus its history, compared with RKLB at down 85%.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
CBAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | -0.8% | -692K shares |
| 3 years | +0.3% | +234K shares |
| 5 years | +5.1% | +4.3M shares |
| Available history | +152% | +53.9M shares |
CBAT has the edge over RKLB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | $263,111 |
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has 652M diluted shares, up 23% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
CBAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2025 | 8.4x | High |
| Q4 2024 | 3.6x | Elevated |
| Q3 2024 | 2.9x | Moderate |
| Q2 2024 | -0.3x | Net Cash |
| Q1 2024 | 1.2x | Healthy |
| Q4 2023 | -1.8x | Net Cash |
CBAT's net debt is about 8.4 years of its operating earnings (EBITDA), up from 1.2 years a year ago.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CBAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.5 | Neutral |
| Stochastic | 48.3 | Neutral |
CBAT's weekly RSI is 52 (neutral) and its Stochastic is 48 (neutral).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
CBAT PE vs Industrials Sector
| Metric | CBAT | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
CBAT has no meaningful PE right now: it lost money over the past year.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
CBAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.08 | 11% below |
| 20 week MA | $0.88 | 9.1% above |
| 50 week MA | $0.85 | 13% above |
| 100 week MA | $0.89 | 7.9% above |
| 200 week MA | $0.97 | 1% below |
CBAT's trend is mixed: it's above three of its five weekly moving averages, and 1% below its 200-week average.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB's trend is mixed: it's above three of its five weekly moving averages, and 104% above its 200-week average.
CBAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.14 | $6.26 | +449% |
| 2021 | $6.26 | $1.69 | -73% |
| 2022 | $1.69 | $0.98 | -42% |
| 2023 | $0.98 | $1.05 | +7.1% |
| 2024 | $1.05 | $1.07 | +1.9% |
| 2025 | $1.07 | $0.86 | -20% |
| 2026 YTD | $0.86 | $0.96 | +12% |
CBAT has the edge over RKLB on returns for 2026, with the stronger performance.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB's yearly returns have swung widely, from +392% in 2024 to −69% in 2022. It's down 9.3% so far in 2026.